On October 20th, 2016, “Puhua Medical Hi Conference”, sponsored by Puhua Capital and Puhua Medical Investment, jointly sponsored by Zhejiang University Zijin Zhongchuang Town, Jingxin Pharmaceutical and CTIC Capital, was successfully held in Hangzhou. Experts, entrepreneurs and investors will jointly discuss the synergy of the “production, research, medical, and investment” of the medical industry.

The head of the Twist Bioscience project conducted a roadshow at the 2016 Puhua Medical Hi Conference. The following is a compilation of the exciting content.

Located in San Francisco, USA, Twist Bioscience currently employs 150 people, has an independent research base, and has a conversion platform for synthesizing DNA on silicon. Twist Bioscience's mission is to provide users with personalized products and experiences that are competitive in terms of production, cost and quality.

Cutting-edge technology with market potential

DNA synthesis is a very promising technology and is currently used in three areas: chemistry, genetic modification, and medical.

It is well known that yeast and sugar can be used to produce alcohol, while Twist Bioscience synthesizes yeast with special DNA on silicon wafers to ferment sugar to produce more chemical products, such as plastic bottles.

In addition, DNA synthesis technology is widely used in transgenic technology: yield or taste is improved by rewriting the genes of plants.

Gene editing is concerned by Microsoft: DNA synthesis medical technology has great potential

Of course, the greater thing about this technology is its application in the medical field. For example, the use of DNA synthesis technology to develop new drug vaccines and other antibodies. The hepatitis B vaccine, which is now very popular, is produced by yeast that uses DNA recombination. There is no doubt that this is of great significance to human health.

The market potential for synthetic DNA is enormous, with two main types of users: buyers and manufacturers. The purchaser obtains the synthetic DNA directly by purchasing. But for manufacturers, they are more inclined to clone, because the price of synthetic DNA is very expensive. What Twist Bioscience wants to do is to advance this process to optimize the market.

FD Green Beans

FD Green Beans,Frozen Dried Green Beans,Freeze Dried Beans, FD Beans

Jiangsu Tiankang Food Co., Ltd. , https://www.tiankangfood.com